Trademark applications and grants for Aurinia Pharmaceuticals Inc.. Aurinia Pharmaceuticals Inc. has 34 trademark applications. The latest application filed is for "LUPUS NEPHRITIS PEER CONNECT"
State Incorporated | CANADA |
Entity Type | COMPANY |
Address | 1203-4464 Markham Street Victoria, B.C. CANADA V8Z7X8 |
Patent Application | Date |
---|---|
PROTOCOL FOR TREATMENT OF LUPUS NEPHRITIS 20220226428 - 17/713140 SOLOMONS; Neil ;   et al. | 2022-07-21 |
OPHTHALMIC COMPOSITIONS 20210338769 - 17/228480 MITRA; Ashim K. ;   et al. | 2021-11-04 |
Ophthalmic Compositions 20200009217 - 16/270760 Mitra; Ashim K. ;   et al. | 2020-01-09 |
PROTOCOL FOR TREATMENT OF LUPUS NEPHRITIS 20190224275 - 16/374701 SOLOMONS; Neil ;   et al. | 2019-07-25 |
PROTOCOL FOR TREATMENT OF LUPUS NEPHRITIS 20180325995 - 15/835219 SOLOMONS; Neil ;   et al. | 2018-11-15 |
SEC | 0001600620 | Aurinia Pharmaceuticals Inc. of ALBERTA, CANADA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.